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In  1970  Abelson  and  Rabstein  (1)  isolated  a  variant  of Moloney leukemia  virus 
from a nonthymic lymphoma of a  BALB/c mouse. Subsequent studies indicated that 
this virus, now termed Abelson murine leukemia virus (MuLV-A), 1 induces a  malig- 
nant  disease  of primitive  bone  marrow-derived  lymphocytes  (2-5).  Under  certain 
conditions,  MuLV-A  also  induces  tumors  of highly differentiated  B  cells,  i.e.  plas- 
macytomas (6). Thus, it is apparent that MuLV-A differs from other murine leukemia 
viruses in its target cell specificity. 
Virologic  studies  indicate  that  MuLV-A  is  a  complex  of  defective  virus  and 
nondefective Moloney leukemia  virus.  The defective virus, which can be assayed in 
vitro by focus formation on certain etablished cell lines, is responsible for the induction 
of nonthymic lymphoma  (7).  Recent  evidence indicates  that  MuLV-A can exert  its 
oncogenic effect on lymphoid cells in tissue culture  (5, 8-10). 
The studies reported here examined the age and virus dose dependence of MuLV- 
A  lymphomagenesis,  and  the  pattern  of susceptibility  of various  mouse  strains  to 
MuLV-A. Results  from studies of BALB/c  ×  C57BL/6 recombinant  inbred strains 
indicate  that  susceptibility  to MuLV-A lymphomagenesis  is  controlled by two  loci, 
designated Av-I and Av-2, at which sensitivity alleles are dominant. Furthermore,  the 
genes involved in this  disease are not identical  to genes controlling other pathologic 
forms of murine leukemia. 
Materials  and Methods 
Animals.  Mouse strains A/J, ABP/J, AKR/J, CBA/CaJ, CBA/H-T6, C3H/HeJ, C57BL/ 
6J,  C57BR/cdJ,  C57L/J,  C58/J,  DBA/2J,  LP/J,  NZB/BinJ,  SEA/GnJ,  and  SJL/J  were 
purchased from The Jackson Laboratory, Bar Harbor, Maine. CXB recombinant inbred strains 
were  obtained  from  Dr.  Donald  Bailey  (The Jackson  Laboratory)  at  F4.~, and  have  been 
subsequently maintained by brother-sister matings for 10-20 generations. BALB.B mice (which 
carry the H-2 region of C57BL/6 on the genetic background of BALB/c), and BALB.K mice 
(which carry the H-2 region of C3H/An on the genetic background of BALB/c) were obtained 
from Dr. Frank Lilly (Albert Einstein College of Medicine). Congenic strains on B10 and B6 
background  were  purchased  from The Jackson  Laboratory.  All  other  mice were  from  the 
National Institutes of Health Small Animal Section (Bethesda, Md.) or bred in our colony at 
the McArdle Laboratory. Hybrid mice were bred in our own colonies; the crosses were made in 
both directions, and data from both directions have been pooled since no statistically significant 
differences were seen in any pair of hybrids. No influence of  sex was observed in the susceptibility 
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of BALB, B6, or hybrid mice to MuLV-A lymphomagenesis. Unless otherwise stated, all mice 
were 2-3x& mo of age when injected. 
Virus.  The original  Moloney virus-derived strain  of MuLV-A was used  throughout  this 
study. Virus pools were prepared as described (6). Five separate pools were used in this study; 
all  were negative for common mouse viruses.  Three pools contained LDH virus, these pools 
showed no differences in their host range in BALB, B6, or recombinant inbred strains or in in 
vivo dose response when compared to pools negative for lactic dehydrogenase virus  (LDV). 
Pools had titers of 104'~-  105.4 focus-forming units (FFU)/ml in NZB-Q cells, and 10  ~'5-10  n'~ XC 
plaque-forming units (PFU)/ml in SC-1 cells. 
Virus Titration.  The defective virus in the MuLV-A complex was titered by focus formation 
on NZB-Q cells, an established fibroblastic line derived from an NZB mouse embryo culture. 
Foci  were scored  at  12-14 days. The  titer  of helper  leukemia  virus was determined  in  the 
standard ultraviolet-XC plaque test  using SC-I cells (11). 
Virus Inoculation.  Mice 3 wk of age or older were inoculated intravenously with 0.1  ml of 
virus  through the  retro-orbital  sinus  while  under ether anesthesia.  Mice  2-6 days old were 
injected with 0.05 ml of virus intraperitoneaily. Mice were observed two to three times a week 
for 90 days post-infection for clinical signs of Abelson lymphoma. Mice were scored as positive 
when they showed clear signs of lymphadenopathy, splenomegaly, or paraplegia. 
Results 
MuLV-A  Lymphomagenesis in Immature and Adult BALB/c and C57BL/6 Mice.  When 
2-6-day-old BALB/cAnN  (BALB)  or C57BL/6N  (B6)  mice were  inoculated  intra- 
peritoneally with MuLV-A, they rapidly developed solid tumors which, on histologic 
examination,  consisted of a  uniform population of immature lymphocytes. The most 
common sites of lymphoma were the vertebral regions and skull, frequently resulting 
in  the  characteristic  "caput"  previously  described  for  Abelson  disease  (1,  2).  The 
latent  period in B6 was longer than that in BALB, though the overall incidence was 
almost  the same  (Fig.  1).  Intravenous inoculation  of virus into  3-wk-old and young 
adult  mice elicited a  quite different response. BALB mice of various ages (1-3½ mo) 
were uniformly sensitive to lymphoma induction, whereas B6 mice were only partially 
sensitive at  1 mo of age, and were essentially resistant  after 6 wk of age (Fig.  1). 
In adult  BALB mice few if any cranial tumors were found, but lymphomas arising 
in  the  lumbar  vertebral  bone  marrow  were  very  frequent.  There  was  generally 
invasion  of tumor cells  into  the  surrounding  vertebral  muscles,  and  indeed,  abnor- 
malities  in  the  gait  of the  mouse, often  progressing to paraplegia,  were among the 
earliest and most reproducible clinical signs of disease in adult BALB mice inoculated 
intravenoulsy  with  MuLV-A.  There  was  usually  moderate  lymphadenopathy,  and 
splenomegaly was common. BALB mice usually died within 5-15 days from the day 
of diagnosis;  in approximately 500 mice diagnosed as having Abelson lymphoma, no 
remissions were observed. 
The few tumors observed in adult  B6 mice differed from those seen in BALB mice 
in  that  massive  lymphadenopathy  of inguinal,  brachial,  or axillary  nodes  was  the 
most  common  clinical  sign  of  disease.  Vertebral  lesions  were  usually  found  on 
histologic examination of diseased B6 mice. Thymic tumors were very rare in mice of 
any strain autopsied in this study, but it must be recalled that mice were not observed 
longer than 90 days. 
Histologic  examination  of tumors  in  weanling  and  adult  mice revealed  uniform 
populations of immature lymphocytes in affected tissues.  Occasional islands of other 
bizarre  cells  were  seen  in  the  bone  marrow  and  spleen.  Toluidine-blue  staining  of 
such  tissues  suggests  that  these  islands  consisted  of transformed  mast  cells.  In  an 716 
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F=~;.  1.  Age  dependence  of the  susceptibility  of BALB  and  B6  mice  to  MuLV-A  lymphoma 
induction.  Mice 2-6 days old were injected  intraperitoneally  with 0.05 ml of MuLV-A (5  X  l0  :~ 
FFU).  Mice  3  wk  and  older  were  injected  intravenously with  0.1  ml  of MuLV-A  (104  FFU). 
Numbers in parentheses are total mice tested. 
independent  study,  a  few transplantable  mastocytomas were obtained  from  BALB 
×  B6 recombinant inbred mice treated with pristane and infected with MuLV-A (J. 
Pumphrey, R. Risser, and M. Potter, unpublished observations). 
Dose Dependence of MuLV-A  Lymphomagenesis in  Adult  BALB and B6 Mice.  Fig.  2 
demonstrates the pattern of response of adult BALB and B6 mice to different doses of 
MuLV-A.  It is  important  to note the relatively narrow range of virus  doses which 
induced  a  high incidence of disease in BALB mice. This response was in contrast to 
most  preparations  of Friend  leukemia  virus,  which  can  be  diluted  approximately 
1,000-fold and still result in high incidences oferythroleukemia in susceptible animals 
(12).  B6 mice were quite unresponsive at all virus doses tested, although by no means 
is the resistance of B6 mice absolute, again in contrast to the resistance of B6 to Friend 
leukemia  virus.  We  have  used  the  dose  of  104  FFU/mouse  for  all  subsequent 
experiments, since it optimizes the difference in responses of BALB and B6 mice. 
The shape of the dose response curve in BALB mice corresponds more closely to a 
one-hit  Poisson  distribution  than  to  multi-hit  distributions;  however,  the  lack  of 
precision in these experiments makes this a  tentative conclusion.  Approximately  103 
in vitro FFU were necessary to induce leukemia in 65% of BALB mice. It is interesting 
to note that the in vitro transformation of bone marrow cells by MuLV-A also appears 
to  be one-hit  and  of comparable sensitivity to  the  in  vivo assay  described  here  in 
terms of FFU per bone marrow cell transformation event (5). 
Sensitivity of Adult Mice of Various Strains to MuL V-A Lymphomagenesis.  The pattern of 
sensitivity of adults of various mouse strains to MuLV-A infection differed consider- 
ably  from  the  distribution  of susceptibility of these  strains  to  infection  with  other 
murine  leukemia  viruses  (Table  I).  BALB  and  strains  related  to  it,  i.e.  BALB.B, 
BALB.K, and SEA, were very sensitive to lymphoma induction.  DBA/2  mice were 
susceptible to lymphoma induction  by MuLV-A, but somewhat less  so than BALB. 
Other strains,  e.g. A/J,  ABP,  LP, may be somewhat sensitive at higher virus doses; REX  RISSER,  MICHAEL  POTTER,  AND  WALLACE  P.  ROWE  717 
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FIG.  2.  Virus dose dependence of MuLV-A lymphoma induction  in adult  BALB and B6 mice. 
Adult mice were injected intravenously with various doses of MuLV-A and observed for lymphoma 
development. Numbers in parentheses indicate the number of mice per point. 
however,  larger  numbers  of mice  must  be  tested  to  establish  this.  Most  strains 
appeared to resemble B6 in having little if any response to MuLV-A when injected as 
adults.  F1 hybrids between BALB and B6 showed sensitivity to MuLV-A similar to 
that of BALB; thus the BALB phenotype is dominant. 
Sensitivity  of CXB Recombinant Inbred Strains to MuL V-A Lymphomagenesis.  The sensi- 
tivity to MuLV-A lymphomagenesis of CXB (BALB ×  B6) recombinant inbred (RI) 
strains,  i.e.  the seven strains of mice generated by Bailey by inbreeding individual 
pairs of CXB F2 mice (13), should give some clues to the host genetic control of this 
disease. The results of infecting adult  mice of the seven strains are shown in Fig. 3. 
Two of the seven CXB recombinant inbred strains, H  and D, resembled the BALB 
parent, whereas one strain, G, resembled the B6 parent  (Fig. 3).  Strain J  was quite 
susceptible to lymphoma induction (76% incidence), although the latent period was 
almost  twice  that  observed  in  BALB  mice.  The  other three strains,  K,  I,  and  E, 
showed a low but reproducible sensitivity to MuLV-A lymphoma induction. 
If one gene controls the differing responses of BALB and B6 mice to MuLV-A, then 
only the parental patterns of sensitivity should be observed when recombinant inbred 
strains are tested. As this is clearly not the case, we can conclude more than one gene 
distinguishes the responses of BALB and B6 mice to MuLV-A. If two unlinked genes 
distinguish  BALB and B6 strains,  then 1/4 of the recombinant inbred strains should 
show the  B6 phenotype, V4 should show the BALB phenotype, and  ½  might show 
other intermediate phenotypes. Thus, our results are consistent with control of MuLV- 
A lymphomagenesis by two genes; however, they by no means rule out more complex 
systems of genetic control. 
From a  comparison of the MuLV-A pattern of susceptibility to the known distri- 
bution of other loci among CXB strains, one can determine if any Abelson-controlling 
gene(s)  can  be  identical  to  a  known  locus  (Table  II).  It  is  clear  that  the  genes 718  ABELSON VIRUS-INDUCED LYMPHOMAGENESIS  IN MICE 
TABLE I 
Sensitivity of Adult Mouse &rams to MuL V-A Lymphoma Induction 
Strain 
10  :j'~ FFU/mouse  10  4.o FFU/mouse 
Leukemic/total  Median latent  Leukemic/total  Median latent pe- 
(%)  period (range)  (%)  riod (range) 
A/J  0/16 (0) 
ABP/J 
AKR/J  0/17 (0) 
BALB/cAnN  41/48 (85)  34 (21-64) 
CBA/CaJ 
CBA/H-T6J  0/10 (0) 
C3tt/HeN 
C57BL/6N  0/50 (0) 
C57BL/6J 
C57BR/cdJ 
C57L/J 
c58/J 
DBA/2N  5/10 (50)  52 (38-63) 
LP/J 
NIH 
NZB/BinJ 
SEA/GnJ 
SjL/j 
3/10 (30)  62 (62) 
4/10 (40)  69 (65-80) 
107/110 (97)  :34 (22-53) 
0/11 (0) 
0/27 (0) 
4/89 (4)  57 (42-85) 
1/14 (7)  84 
0/10 (0) 
0/10  (0) 
0/16  (0) 
16/20 (80)  38 (26-56) 
4/14 (29)  75 (65-90) 
1/10 (10)  60 
0/21 (0) 
7/13 (54)  53 (40-66) 
1/16 (6)  65 
Congenic strains 
BALB.B  27/27 (100)  34 (18-55) 
BALB.K  10/11 (91)  38 (:36-80) 
B6.C-ti-2a(|twIg)  2/8 (25)  85 (79-90) 
B6.C-tt-2a(HW41)  4/17 (24)  75 (58-85) 
B6.C-H-2d(HWI01)  5/16 (31)  80 (55-85) 
B6.C-H-36~(HW59)  2/27 (7)  65 (50-80) 
B 10.C  (28NX)  0/10 (0) 
B 10.D2(old)  0/8 (0) 
Itybrid Mice 
BALB ×  B6 F,  40/53 (75)  41 (26-75)  58/67 (87)  44 (30-57) 
K x J  l,',  14/17 (82)  45 (30-75)  :39/42 (93)  :33 (28-55) 
controlling susceptibility  to MuLV-A lymphomagenesis cannot  be identical  to Fv-2, 
Gpd-I  (Fv-1  region), IgCH, or loci controlling susceptibility  to pristane-induced  plas- 
macytomagenesis  (14-19),  as inconsistencies  are found in both directions  (Table II). 
Three  histocompatibility  loci  show  a  strain  distribution  pattern  similar  to  that  of 
MuLV-A lymphomagenesis among CXB recombinant  inbred strains,  H-2, H-3, and 
H-36 (15).  Testing of the appropriate congenic strains,  i.e.  B10.C(28NX)  in the case 
of H-3,  and  B6.C-H-36  c in  the  case of H-36  (Table  I),  suggested  these  loci  do  not 
influence susceptibility of MuLV-A. H-2 or genes linked to it may well play a role in 
susceptibility to MuLV-A, as will be discussed later. 
Sensitivity of Hybrids between RI Strains to MuL V-A Lymphomagenesis.  The genetic basis 
for the different  MuLV-A sensitivity  patterns  shown by RI strains  may be resolved 
through a study of susceptibility of hybrids made between strains. Since susceptibility 
is dominant in (BALB ×  B6)F1 mice, clear examples ofcomplementation for increased REX  RISSER,  MICHAEL  POTTER,  AND  WALLACE  P.  ROWE  719 
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Fic.  3.  The response of BALB  X  B6 (CXB)  RI strains to MuLV-A lymphoma induction. Adult 
mice were injected with l0  s FFU/mouse intravenously. The number of mice per strain is indicated 
in parentheses. 
tumor  response  might  be  expected  when  different  sensitivity  alleles  are  brought 
together in a hybrid animal. If two strains do not differ in MuLV-A sensitivity alleles, 
the hybrid between them should show the parental pattern of response. 
The  simplest  interpretation  of the  data  to  be  presented  below,  obtained  from 
hybrids of RI strains, is that BALB mice carry two loci, tentatively designated Av-1 
and Av-2, which independently confer on these mice partial sensitivity to MuLV-A 
lymphoma induction. In this model, strain J  carries the dominant BALB sensitivity 
allele at the Av-1 locus (genotype Av-1  s, Av-2r),  which results in a  high but delayed 
incidence of MuLV-A lymphomas, whereas strains K, E, and I  carry the dominant 
BALB sensitivity allele at the Av-2 locus (genotype Av-f, Av-2S),  which results in a 
moderate incidence of lymphomas. Strains BALB, H, and D  carry sensitivity alleles 
at both loci (genotype Av-1  s  Av-lS), whereas strains G and B6 carry sensitivity alleles 
at neither, (genotype Av-f, Av-2r). 
The distinction between Av-1 and Av-2 loci was demonstrated by the clear comple- 
mentation  for tumor  response when  these  genes were combined  in  hybrid double 
heterozygotes (BALB X  B6 Ft, H  X  G  Ft, J  X  I F~,J  X  K  Ft andJ  x  E F1), and 
clear lack of complementation for tumor response in hybrid Av-2 homozygotes (K  × 
I Ft, K  x  E F1, E  X  I  Ft)  (Fig. 4, Table III). Thus, the phenotype of hybrids H  × 
G, J  x  I, J  x  K, and J  x  E was not significantly different from that of (BALB X 
B6)Ft mice, implying that these hybrids carry sensitivity alleles at all relevant MuLV- 
A  susceptibility genes. These results further imply that alleles conferring sensitivity 
are dominant  at both loci. The hybrids K  ×  I  Ft, K  X  E  F1, and E  X  I  Fa were 
phenotypieally indistinguishable  in  their  response  to  MuLV-A  from  the  parental 
strains K, E, or I  (Fig. 4, Table III). From this, we infer that the parental strains are 
genotypically identical. 
The dominant nature of  sensitivity alleles was confirmed in tests of  the susceptibility 
of hybrids of sensitive strains  with  the  resistant  strain  G. J  x  G  F1  mice were as 
susceptible to MuLV-A lymphoma induction as J  mice; K  ×  G F1 mice were similar 
to  K  mice  in  response,  and  I  X  G  Ft  mice  were  as  sensitive  as  I  mice  (Fig.  4). 
Confirmation of this  model will come through  tests of first and second generation 
backcross mice, experiments which are in progress. 
The role of the H-2 Gene Complex in MuL V-A Lymphomagenesis.  Since CXB strains H 720  ABELSON  VIRUS-INDUCED LYMPHOMAGENESIS  IN  MICE 
TABLE II 
A Comparison of Sensitivity to MuLV-A Lymphomagenesis to the Distribution of Known Loci Among CXB 
RI Strains* 
Strain  MuLV-A1:  Gpd- 1  (Fv-1)  Fv-2  H-2  It-3  IgCn  H-36  PCT  Av-l§  Av-2§ 
CXB D  93%(40)  C  C  C  C  B  C  C-B  C  C 
CXB E  24%(62)  C  C  B  B  B  B  C-B  B  C 
CXB G  4%(60)  C  C  B  B  C  B  C  B  B 
CXB I t  95%(40)  B  B  C  C  B  C  B  C  C 
CXB I  30%(57)  C  B  B  B  B  C  B  B  C 
CXB J  76%(57)  B  C  B  B  C  B  C  C  B 
CXB K  38%(57)  B  C  B  B  B  C  B  B  C 
* C indicates inheritance of the BALB/c allele, B indicates inheritance of the C57BL/6 allele. Distribution 
of loci based on references (15-17). PCT indicates the susceptibility of these strains to pristane induction 
of plasmacytomas (16). 
The percentage of MuLV-A lymphomas and the median latent period (in days) in adult mice infected 
with 104 FFU is indicated for each of the RI strains. 
§ See Discussion. C sensitivity alleles are dominant (S) to B resistance alleles (r). 
and  D  are  like  BALB  in  their  sensitivity to  MuLV-A,  and  also  inherit  their H-2 
regions  from  BALB,  we  tested  the  hypothesis  that  H-2  is  a  major  determinant  of 
MuLV-A sensitivity by testing the susceptibility of appropriate H-2 congenic strains 
to MuLV-A. The data in Table I and Fig. 5 demonstrate that BALB.B mice, congenic 
with BALB except for the 11-2 region from B6, were uniformly sensitive to MuLV-A, 
as were n-2  b/b RI hybrid miceJ  x  I F1, J  x  K  F1, andJ  ×  E F1. On the other hand, 
B6.C-H-2  d mice, congenic with B6 except  for 1-1-2 from  BALB  (14), were somewhat 
more sensitive to MuLV-A than were B6 mice. 
These seemingly contradictory results may indicate that  the H-2 locus can play a 
minor role in determining susceptibility of B6 mice to MuLV-A, its effect being seen 
only when the rest of the genotype is resistant. The sensitivity genes carried by BALB 
can be considered epistatic to H-2, so that H-2 does not appear as a mjaor determinant 
of susceptibility in mice carrying the BALB susceptibility alleles at Av-1 and Av-2 loci. 
Since these BALB alleles are dominant for sensitivity, a  prediction of this hypothesis 
is that  in hybrid mice that are heterozygous for all BALB and B6 genes except H-2, 
the H-2 type should not affect the response to MuLV-A. The incidence curves in Fig. 
5 clearly indicate that hybrids BALB/c  X  C57BL/6  (H-2b/d), BALB/c  X  B6.C-H-2 d 
(H-2d/d), and BALB.B  X  C57BL/6 ('H-2  b/b) were indistinguishable in their responses 
to MuLV-A. Thus, though the introduction of the H=2  d haplotype into the B6 genetic 
background can increase somewhat the sensitivity of these mice to MuLV-A, the H- 
2 complex is not a  major independent locus distinguishing the response of BALB and 
B6 mice to MuLV-A, at least at the high virus doses used  (104  FFU/mouse). It may 
well  be  that  lower  virus  doses  would  reveal  a  major  effect  of H-2  on  MuLV-A 
susceptibility, as has been found for Friend virus disease (20). 
Virus Growth Curves in Adult BALB and B6 Mice.  The  growth  of both  helper and 
defective  transforming  viruses  of  the  MuLV-A  complex  in  target  vertebral  and 
lymphoid tissues of adult BALB and B6 mice is shown  in Fig. 6.  It is apparent that 
the Moloney helper virus grew well in both strains; the growth kinetics in the first 2 
wk  were  very  similar,  but  thereafter  virus  reached  about  10-fold  higher  titers  in 
BALB. In contrast, the defective transforming virus was almost completely restricted I00 
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were injected with 104 FFU/mouse intravenously. Data from matings in each direction, e.g.,  BALB 
~  X  B6 ~ and B6 d  x  BALB 2, have been combined for each set of hybrids. The number of mice 
tested is indicated in parentheses. 
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in the resistant B6 mice. This restriction was seen both during the latent period and 
at the time when BALB mice are lymphomatous. As might be anticipated from the 
pathology of Abelson disease in BALB mice, transforming virus was detected earlier 
and in higher titers in the vertebral tissues than in lymphoid tissues; its appearance 
in peripheral lymphoid organs may represent dissemination of tumor cells from the 
vertebral bone marrow. These results suggest that the restrictions operating on MuLV- 
A  in B6 mice do not act by restricting the growth of Moloney helper virus, but are 
specific for the defective MuLV-A transforming genome. 
Discussion 
Certain of our observations suggest the pathogenetic mechanism of Abelson lym- 
phoma differs from that of other forms of murine leukemia. The strain from which 
MuLV-A  orginated,  BALB,  is  acutely  sensitive  to  the  induction  of  lymphoma 
throughout  the  age range tested  (2-6 days to  3a/2 mo).  Most  other strains,  though 
sensitive as newborn mice (1), are essentially resistant by 2-3 mo of age. The frequency 
of lymphoma induction was linearly dependent on the dose of virus administered, 
103.2 in vitro FFU being sufficient to induce lymphoma in 63% of adult BALB mice. 
In contrast,  104.5 FFU, the maximum dose achievable, induced lymphomas in only 
7% of adult B6 mice. In hybrids of these two strains sensitivity is essentially dominant, 722  ABELSON VIRUS-INDUCED LYMPHOMAGENESIS IN  MICE 
TABLE III 
MuL V-A Lymphomagenesis among Mice of Different Av-I and Av-2 Genotypes 
Proposed genotype  Mouse  Lymphoma  Median latent  Number 
incidence  period  tested 
Av_IS/- Av.2S/- 
Av_lS/- Av_2r/~ 
Av- 1  ~/~ Av-2  s/- 
Av° ]r/r Av.2rl, 
BALB  97  34  110 
H  97  40  32 
D  93  40  28 
CBFI*  87  44  67 
H ×  G FI  94  36  34 
J  x  K F1  93  33  42 
J  x  E  F~  88  40  16 
J  ×  I F~  86  45  22 
Total  93  36  351 
j  75  57  56 
J  X, GF~  79  51  24 
Total  76  55  80 
K  38  57  42 
I  30  57  47 
E  24  57  46 
K ×  G FI  36  42  25 
I  ×  G  FI  36  75  28 
K X I F~  33  57  33 
K X E F~  40  50  25 
E X I F~  28  52  36 
Total  33  55  282 
G  4  60  48 
B6  4  57  89 
Tot  al  4  57  137 
* CBFh (BALB/cAnN ×  C57BL/6N)Fx. 
in that 87% of the F1 mice registered as sensitive, even though the latent period was 
somewhat prolonged. 
The basis for the differing responses of BALB and B6 is multigenic in character, 
and the genes involved are not those which control susceptibility to Friend virus, i.e. 
Fv-l, Fv-2 (14), or H-2.  Since the pseudotype of MuLV-A used in these studies is the 
NB-tropic Moloney virus, and BALB and B6 mice are not thought to differ at the Fv- 
1  locus  (18,  19),  it  is  expected  and  reassuring to  note  no  correlation of MuLV-A 
susceptibility with the inheritance of this region among CXB strains. 
It is also interesting to note that Fv-2, a  locus at which BALB carries the dominant 
susceptibility allele (14), does not appear to be involved in susceptibility to Abelson 
virus-induced lymphomagenesis  (Table  II).  Several  aspects  of  genetic  control  of 
MuLV-A lymphomagenesis resemble control of Friend virus disease by Fv-2. In both 
cases  the  genes appear  to  affect  the  transforming virus  (14,  21),  and  in both cases 
resistance is recessive. Also, genetic resistance to Friend or Abelson disease appears to 
depend  upon  intact  immunological systems,  as  shown  by  the  age  dependence of 
resistance (22, 23; Fig.  1). 
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Fic.  5.  The effect of/-/-2 on MuLV-A lymphoma induction. Mice were injected with  ]0  4 FFU/ 
mouse. The incidence curve of B6.C-H-2  d is drawn from the combined data on strains |]WI9, 
I[W41, and ItW101, each of which is an independent isolation of the B6.C-H-2  a genotype (15). For 
a breakdown of this data see Table I. 
tO MuLV-A lymphoma induction;  however, such effects are seen only in the absence 
of sensitivity alleles carried at  other loci in  the BALB  mouse genome.  In addition, 
susceptibility to MuLV-A  lymphoma induction  is apparently not  mediated  by the 
genes that control sensitivity to pristane induction of plasmacytomas (16), a tumor of 
highly differentiated B cells. 
Data  from the CXB  RI strains clearly exclude the possibility of one major gene 
controlling  MuLV-A  lymphoma induction.  Our  results are consistent  with  the  hy- 
pothesis that BALB mice carry two genetic loci, tentatively designated Av-I and Av-2, 
which  differentiate  their response to MuLV-A  from that  of B6 mice.  Based on the 
high susceptibility of F1 mice and RI strain hybrids, we suggest that the BALB allele 
is in each case dominant or semidominant for sensitivity. In this model, homozygosity 
of the BALB allele at the Av-I locus results in a delayed high incidence of lymphoma, 
e.g.  CXB  J;  homozygosity  of  the  BALB  allele  at  the  Av-2  locus  results  in  the 
appearance of a low frequency of lymphomas, e.g. CXB E, CXB K, and CXB I; and 
homozygosity of BALB alleles at both loci results in the BALB/c phenotype, e.g. CXB 
H, and CXB D. 
The mechanisms by which B6 mice resist the lymphomagenic action of MuLV-A 
are probably numerous. The striking age dependence of :~esistance  suggests that one 
mechanism involves immune recognition and rejection of tumor cells. Resistance to 
MuLV-A is clearly not via a  dominant immune response as suggested for Rgv-1  (24), 
since resistance is recessive. Recent serologic experiments have detected an Abelson 
specific antigen common to cells transformed by MuLV-A and lymphoid subpopu- 
lations  of BALB  mice  (25).  The  strain  distribution  of Abelson  antigen  expression 
among the seven Bailey RI strains coincides, with the inheritance of the BALB Av-2 s 
allele,  suggesting  that  Abelson  antigen  is  in  some  manner  controlled  by Av-2  (R. 
Risser,  unpublished  observations).  The  Av-2  locus  might  thus  effect  sensitivity  by 
partially tolerizing mice to antigens expressed on MuLV-A tumor cells. 
Genetic resistance is probably not at the level of helper virus function, as the titers 
of Moloney virus recovered from susceptible and resistant animals were not markedly 
different. The Av-I  r allele may interfere with the initiation of infection, replication, or 
(19) BALB BxB6  (H-2b/b) 
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Post-Infection 
The growth of MuLV-A in adult BALB and B6 mice. Mice 6-8 wk of age were injected 
intravenously with 104 FFU of MuLV-A. At the times indicated mice were sacrificed, the vertebral 
column and the pooled lymphoid organs consisting of spleen plus brachial, axillary, inguinal, and 
mesenteric lymph nodes of individual mice were removed, weighed, and a  10% wt/vol extract  was 
prepared for each of the two tissues. Extracts were titered  for FFU (O) on the NZB-Qcell line, and 
for PFU (Q)) on the SC-I  cell line using the ultraviolet-XC plaque procedure (11). Thus, each 
mouse generates four data points: PFU and FFU on vertebral  tissue, and PFU and FFU on pooled 
lymphoid organs. 
cell  transformation  by  the  defective  transforming  virus  genome.  Studies  on  virus 
recovery  from  RI  strains carrying Av-1  and, :4v-2 sensitivity alleles may  clarify  this 
question.  In  this  regard,  it  is  interesting to  note  that  Rosenberg and  Baltimore  (5) 
observed BALB bone marrow cells to be more susceptible to MuLV-A  transformation 
in vitro than B6 cells. The strain pattern observed  by them  in in vitro tests differed 
from  that  observed  by us in vivo, in that  several strains register as sensitive in vitro 
but  not  in  vivo,  e.g.  A/J,  NIH,  and  C57L.  This  could  quite  possibly  be  due  to 
additional genes influencing immunological mechanisms in vivo. REX RISSER, MICHAEL POTTER, AND WALLACE P.  ROWE  725 
Summary 
The salient  facts which have emerged from our study of Abelson virus (MuLV-A) 
lymphomagenesis in mice are that lymphoma induction is (a) age dependent, (b) virus 
dose  dependent,  and  (c)  under  the  control  of host  genes  unrelated  to  other  genes 
known  to  control  murine  leukemia  (e.g.,  Fv-1  or  Fv-2).  Of  16  strains  tested,  only 
BALB/c and some of its derivative strains showed high sensitivity. Studies from CXB 
recombinant inbred strains and hybrids between them are interpreted to indicate that 
BALB/c carries dominant sensitivity alleles  at  two loci, tentatively designated Av-I 
and Av-2,  which confer on these mice partial  susceptibility to MuLV-A lymphoma 
induction. In addition, H-2 may play a  minor role in determining the susceptibility 
of mice to MuLV-A, its effect being seen only in mice homozygous for resistance at 
both Av-l  and Av-2.  Virologic studies indicate that the resistance of adult B6 mice is 
not related to restriction on the helper virus replication, but is specific for the defective 
transforming virus genome. 
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